Dr Reddys Laboratories (RDY) FCF Margin (2009)

Dr Reddys Laboratories (RDY) posted quarterly FCF Margin of 40.05% for Q4 2009, down 36.15% quarter-over-quarter from 62.72% in Q3 2009.

Dr Reddys Laboratories (RDY) FCF Margin (2009) Analysis & Trends

Dr Reddys Laboratories' FCF Margin history runs 1 years deep, the most recent figure standing at 40.05% for Q4 2009.

In Q4 2009, FCF Margin changed N/A year-over-year to 40.05%; the TTM figure through Sep 2010 stood at 10.55% (down 1727.0% YoY), while the FY2026 annual figure was 10.0%, up 415.0% from the prior year.
FCF Margin for Q4 2009 stood at 40.05%, down from 62.72% in the prior quarter.
The five-year high for FCF Margin was 62.72% in Q3 2009, with the low at 40.05% in Q4 2009.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Margin (Qtr)
1	Haleon	44.07 Bn	43.10 Bn	-	-
2	Teva Pharmaceutical Industries	43.42 Bn	39.76 Bn	2.15 Bn	7.41%
3	Zoetis	31.86 Bn	30.18 Bn	1.05 Bn	21.80%
4	Takeda Pharmaceutical	28.77 Bn	22.98 Bn	5.10 Bn	14.87%
5	United Therapeutics	22.29 Bn	19.63 Bn	683.80 Mn	26.25%
6	Viatris	18.78 Bn	17.89 Bn	1.46 Bn	8.76%
7	Neurocrine Biosciences	15.66 Bn	15.27 Bn	935.80 Mn	13.41%
8	Elanco Animal Health	11.91 Bn	11.38 Bn	798.00 Mn	17.84%
9	Dr Reddys Laboratories	10.16 Bn	10.00 Bn	-	-
10	Alkermes	8.20 Bn	7.55 Bn	397.90 Mn	27.63%

Download Data